![]() |
Technical Note: Papain Adulteration in 11-nor-Δ9-Tetrahydrocannabinol-9-carboxylic Acid-Positive Urine SamplesIssue Date: July/August 2008Volume Number: 32 Issue Number: 6 Page Numbers: 438–443 Authors: Scott J. Larson, Justin M. Holler, Joseph Magluilo, Jr., Christopher S. Dunkley, and Aaron Jacobs |
|
|
Price (Article):
$40.00
|
||
| Ask a question about this product | ||
Scott J. Larson1, Justin M. Holler1, Joseph Magluilo, Jr.1, Christopher S. Dunkley1, and Aaron Jacobs2 1Division of Forensic Toxicology, The Armed Forces Medical Examiner System, Armed Forces Institute of Pathology, Rockville, Maryland 20850 and 2Air Force Medical Operations Agency, Brooks City-Base, Texas 78235 The adulteration of urine samples is an ongoing problem in forensic drug-testing laboratories, even in the military where the practice of observed collections is performed. These adulterants are used to produce a false-negative result when samples are analyzed for drugs of abuse. It has been reported that papain, a cysteine protease, could be successfully used as a urine adulterant, altering the concentration of 11-nor-Δ9-tetrahydrocannabinol-9- carboxylic acid (THCCOOH) in urine samples. The current study analyzes the effects of latex papain (Sigma, 10 mg/mL) and Lawry's® Adolph's Meat Tenderizer (papain is an active ingredient, 10 mg/mL) on immunoassays (FPIA, EMIT, KIMS) and gas chromatography-mass spectrometry (GC-MS) analysis for biological samples. The samples were analyzed initially between 2 and 4 h and then at 1-, 3-, 7-, and 10-day time intervals after the addition of papain. A decrease in response averaged over the course of the study was observed with FPIA (Abbott, 22%) and EMIT (Syva® Dade Behring, 26%, Microgenics, 10%) screening assays by the addition of latex papain to the samples. An increase in response was found using the KIMS (Roche) assay (156% increase). In addition, the GC-MS results (27% decrease) demonstrate that papain affects both the screening and confirmation assays. The addition of meat tenderizer caused a decrease in the FPIA (Abbott, 11%) screening assay and GC-MS results (22%) similar to the latex papain while having varied results on the other screening assays. This study confirms papain could be a potential problem for urine drug-testing programs. Journal of Analytical Toxicology, July/August 2008, Volume 32, Number 6, pages 438–443. |
||
|
|
||
Customer Reviews:There are yet no reviews for this product.Please log in to write a review. |
||